Target intelligence / Profile preview

Ajuba LIM protein (AJUBA)

Target
AJUBA
Molecular classification
Scaffold/adapter protein, LIM domain-containing protein, Transcriptional corepressor, Signal transduction modulator, Cytoskeletal regulator
01

Overview

Ajuba LIM protein is a versatile scaffold and transcriptional corepressor that regulates cell adhesion, cytoskeletal organization, mitosis, gene transcription, hypoxic response, cell proliferation, differentiation, migration, and apoptosis. It connects membrane and nuclear events, integrating diverse signaling pathways such as Hippo, JAK/STAT, IL-1, and MAPK. Structurally, AJUBA has three C-terminal LIM domains (double zinc fingers) and a proline-rich N-terminal preLIM domain with nuclear export and protein–protein interaction features. AJUBA's aberrant expression or localization participates in EMT, metastasis, and tumor progression, and alters prognosis in many cancer types. Its molecular complexity and involvement in a variety of essential functions make AJUBA both a critical biological regulator and a challenging, but potentially valuable, therapeutic target.

Other names
LIM domain-containing protein ajubaJUBAJUBA_HUMANMGC15563jubajuba homolog
02

Mechanism of action

For hypothetical drugs targeting AJUBA: Inhibition of its scaffolding or adaptor function; Disruption of AJUBA-dependent protein complexes; Modulation of Hippo pathway activity (e.g., affecting YAP1 phosphorylation); Inhibition of its effect on EMT and metastatic gene expression.

03

Biological functions

Cell adhesionCytoskeletal organizationMitosis and chromosome segregationSignal transduction (Hippo, IL-1, JAK/STAT, MAPK)Cell cycle regulationGene transcription and repressionCell differentiation and fate determinationCell migration and proliferationApoptosismicroRNA-mediated gene silencingHypoxia response
04

Disease associations

Cancer (colorectal, hepatocellular, pancreatic, breast, gastric, prostate, esophageal squamous cell carcinoma, glioma, head and neck, cholangiocarcinoma)Inflammation (role in IL-1 and NF-κB signaling)Potential developmental diseases (neural crest development)Other (adipogenesis/metabolic disorders via PPARγ)
05

Safety considerations

Inhibition could impact normal cell adhesion, proliferation, and tissue integrityRisks to developmental processes and tissue homeostasis due to its broad regulatory rolePotential effects on immune regulation and hypoxia response
06

Interacting drugs

No approved drugs known to specifically target AJUBA directly.
07

Biomarkers

AJUBA expression level (for cancer prognosis and progression)Co-expression with EMT markers (e.g., N-cadherin, Twist, YAP1, MMPs)Association with fibroblasts and cancer microenvironmentPotential: molecular signatures in the Hippo pathway

Beyond the preview

Go deeper on Ajuba LIM protein (AJUBA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ajuba LIM protein (AJUBA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call